Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Bureau G, Berchier MC, Zacharias C, Mommen P, Bosschaerts T, Berghmans T, van Houtte P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: recloux p. Ann Oncol. 1999 Mar;10(3):295-303. doi: 10.1023/a:1008319506107. Ann Oncol. 1999. PMID: 10355573 Free article. Clinical Trial.
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Sculier JP, Paesmans M, Ninane V, Giner V, Bureau G, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Berchier MC, Zacharias C, Mommen P, van Houtte P, Klastersky J. Sculier JP, et al. Among authors: recloux p. Lung Cancer. 1998 Dec;22(3):201-13. doi: 10.1016/s0169-5002(98)00089-0. Lung Cancer. 1998. PMID: 10048473
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Lecomte J, Berghmans T, Thiriaux J, Florin MC, Efremidis A, Alexopoulos CG, Recloux P, Ninane V, Mommen P, Paesmans M, Klastersky J; European Lung Cancer Working Party. Sculier JP, et al. Among authors: recloux p. Ann Oncol. 2002 Jun;13(6):874-82. doi: 10.1093/annonc/mdf154. Ann Oncol. 2002. PMID: 12123332 Free article. Clinical Trial.
Internal hemipelvectomy.
Hamdi M, Gebhart M, Recloux P. Hamdi M, et al. Among authors: recloux p. Eur J Surg Oncol. 1996 Apr;22(2):158-61. doi: 10.1016/s0748-7983(96)90697-6. Eur J Surg Oncol. 1996. PMID: 8608833
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy.
Sculier JP, Berghmans T, Lafitte JJ, Richez M, Recloux P, Van Cutsem O, Ninane V, Mommen P, Paesmans M, Klastersky J; European Lung Cancer Working Party. Sculier JP, et al. Among authors: recloux p. Lung Cancer. 2002 Jul;37(1):73-7. doi: 10.1016/s0169-5002(02)00037-5. Lung Cancer. 2002. PMID: 12057870 Clinical Trial.
Ureteral obstruction in patients with breast cancer.
Recloux P, Weiser M, Piccart M, Sculier JP. Recloux P, et al. Cancer. 1988 May 1;61(9):1904-7. doi: 10.1002/1097-0142(19880501)61:9<1904::aid-cncr2820610930>3.0.co;2-1. Cancer. 1988. PMID: 3355980
A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer.
Sculier J, Thiriaux J, Bureau G, Lafitte J, Recloux P, Brohee D, Berchier M, Sergysels R, Mommen P, Paesmans M, Klastersky J, Lecomte J, Vanschaardenburg C, Richard V, Diana D, Fortin F, Tagnon A, Kustner U. Sculier J, et al. Among authors: recloux p. Int J Oncol. 1995 Feb;6(2):425-9. doi: 10.3892/ijo.6.2.425. Int J Oncol. 1995. PMID: 21556555
12 results